Vor Bio to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass., March 04, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences:

Barclays 26th Annual Global Healthcare ConferenceFireside Chat: Tuesday, March 12, 2024 at 4:35 pm ET Location: Miami, FL

A live webcast and archived replay of the fireside chat will be available on the investors section of www.vorbio.com.

H.C. Wainwright 2nd Annual Cell Therapy Virtual ConferenceFireside Chat: Tuesday, March 26, 2024 at 2:30 pm ET Location: Virtual

About Vor BioVor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:Media & InvestorsSarah Spencer +1 857-242-6076[email protected]

You May Also Be Interested In

• Iberia Cards Moves Beyond Point-in-Time Compliance with Synack
• New board members to transform Thames Water announced
• Aegon implements EUR 150 million increase in share buyback program